International Immunopharmacology

Papers
(The H4-Index of International Immunopharmacology is 56. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
The purinergic receptor P2X3 promotes facial pain by activating neurons and cytokines in the trigeminal ganglion959853577
Dihydroartemisinin alleviates erosive bone destruction by modifying local Treg cells in inflamed joints: A novel role in the treatment of rheumatoid arthritis892668210
Optimized rituximab regimen versus recommended regimen for idiopathic membranous nephropathy: A single-center retrospective cohort study858927665
Fragility index analysis for randomized controlled trials of approved biologicals and small molecule drugs in inflammatory bowel diseases805908745
Performance of assessment tools in predicting neural autoantibody positivity in patients with seizures758133037
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients627
The role of JAK/STAT signaling pathway and its inhibitors in diseases403
Breast cancer: Biology, biomarkers, and treatments286
MCP-1: Function, regulation, and involvement in disease278
COVID-19 vaccine hesitancy and related fears and anxiety225
Effect of gut microbiota on LPS-induced acute lung injury by regulating the TLR4/NF-kB signaling pathway183
Nano-curcumin therapy, a promising method in modulating inflammatory cytokines in COVID-19 patients174
Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment148
Anti-inflammatory and M2 macrophage polarization-promoting effect of mesenchymal stem cell-derived exosomes138
Interferon β-1b in treatment of severe COVID-19: A randomized clinical trial136
CTLA-4: From mechanism to autoimmune therapy122
Neutrophils and COVID-19: The road so far122
Use of Machine Learning and Artificial Intelligence to predict SARS-CoV-2 infection from Full Blood Counts in a population121
Baricitinib, a drug with potential effect to prevent SARS-COV-2 from entering target cells and control cytokine storm induced by COVID-19118
Towards treatment planning of COVID-19: Rationale and hypothesis for the use of multiple immunosuppressive agents: Anti-antibodies, immunoglobulins, and corticosteroids117
Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives111
Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality98
The possible of immunotherapy for COVID-19: A systematic review97
Toll-like receptors in sepsis-associated cytokine storm and their endogenous negative regulators as future immunomodulatory targets97
Clinical and laboratory features of COVID-19: Predictors of severe prognosis90
The WHO International Standard for COVID-19 serological tests: towards harmonization of anti-spike assays88
COVID-19 and cancer: From basic mechanisms to vaccine development using nanotechnology87
The roles of macrophage polarization in the host immune response to sepsis87
Dimethyl fumarate improves cognitive deficits in chronic cerebral hypoperfusion rats by alleviating inflammation, oxidative stress, and ferroptosis via NRF2/ARE/NF-κB signal pathway83
Mechanisms of immune escape in the cancer immune cycle82
Fibroblast-like synoviocytes in rheumatoid arthritis: Surface markers and phenotypes79
SARS-Cov-2 infection: Response of human immune system and possible implications for the rapid test and treatment79
Abscopal effect in radioimmunotherapy75
Pharmacological approaches to mitigate neuroinflammation in Alzheimer’s disease73
Potential adjuvants for the development of a SARS-CoV-2 vaccine based on experimental results from similar coronaviruses72
Stigmasterol protects rats from collagen induced arthritis by inhibiting proinflammatory cytokines71
TIM-3: An update on immunotherapy71
Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-1970
Molecular hydrogen attenuates sepsis-induced neuroinflammation through regulation of microglia polarization through an mTOR-autophagy-dependent pathway70
Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation70
Damage-associated molecular patterns in tumor radiotherapy69
Ferrostatin-1 alleviates angiotensin II (Ang II)- induced inflammation and ferroptosis in astrocytes68
The deregulated immune reaction and cytokines release storm (CRS) in COVID-19 disease67
IFN regulatory Factor-1 induced macrophage pyroptosis by modulating m6A modification of circ_0029589 in patients with acute coronary syndrome67
Acute and post-acute phase of COVID-19: Analyzing expression patterns of miRNA-29a-3p, 146a-3p, 155-5p, and let-7b-3p in PBMC66
The role of chemokines and chemokine receptors in multiple sclerosis64
Astragaloside IV promotes microglia/macrophages M2 polarization and enhances neurogenesis and angiogenesis through PPARγ pathway after cerebral ischemia/reperfusion injury in rats63
A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines63
microRNA-421-3p prevents inflammatory response in cerebral ischemia/reperfusion injury through targeting m6A Reader YTHDF1 to inhibit p65 mRNA translation62
Autoimmune phenomena following SARS-CoV-2 vaccination61
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection59
Predictive value of neutrophil-lymphocyte ratio and platelet-lymphocyte ratio in non-small cell lung cancer patients treated with immune checkpoint inhibitors: A meta-analysis59
Tocilizumab for treatment patients with COVID-19: Recommended medication for novel disease58
Identification of immune-related lncRNA signature for predicting immune checkpoint blockade and prognosis in hepatocellular carcinoma57
Combined evaluation of the expression status of CD155 and TIGIT plays an important role in the prognosis of LUAD (lung adenocarcinoma)57
Subcutaneous administration of interferon beta-1a for COVID-19: A non-controlled prospective trial56
Clostridium butyricum modulates gut microbiota and reduces colitis associated colon cancer in mice56
0.047649145126343